- Home
- HALO vs QS Comparison
HALO vs QS Comparison
Compare HALO & QS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HALO | QS |
|---|---|---|
| Founded | 1998 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 7.5B |
| IPO Year | 2001 | 2020 |
Fundamental Metrics
Financial Performance| Metric | HALO | QS |
|---|---|---|
| Price | $66.60 | $7.97 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 6 |
| Target Price | ★ $78.64 | $9.38 |
| AVG Volume (30 Days) | 1.2M | ★ 19.1M |
| Earning Date | 05-05-2026 | 04-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 19.15 |
| EPS | ★ 2.56 | N/A |
| Revenue | ★ $151,862,000.00 | N/A |
| Revenue This Year | $28.24 | N/A |
| Revenue Next Year | $12.56 | $1,827.70 |
| P/E Ratio | $25.74 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $47.50 | $3.80 |
| 52 Week High | $82.22 | $19.07 |
Technical Indicators
Market Signals| Indicator | HALO | QS |
|---|---|---|
| Relative Strength Index (RSI) | 55.68 | 65.85 |
| Support Level | $63.85 | $7.40 |
| Resistance Level | $68.00 | $9.61 |
| Average True Range (ATR) | 1.98 | 0.66 |
| MACD | 0.03 | 0.08 |
| Stochastic Oscillator | 61.46 | 44.74 |
Price Performance
Historical ComparisonAbout HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
About QS QuantumScape Corporation
QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles and other applications. The company's solid-state lithium-metal battery technology is designed to offer greater energy density, faster charging, and enhanced safety. Its battery cells have none of the host materials used in conventional anodes.